Financhill
Back

Zevra Therapeutics Quote, Financials, Valuation and Earnings

The AI Energy Miracle

Details Here.
Sell
44

ZVRA
Zevra Therapeutics

Last Price:
$8.49
Seasonality Move:
-0.81%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

Zevra Therapeutics Price Quote

$8.49

Zevra Therapeutics Key Stats

Sell
44
Zevra Therapeutics (ZVRA) is a Sell

Day range:
$8.34 - $8.83
52-week range:
$4.20 - $9.76
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.75
P/B ratio:
6.5%

Volume:
2.5M
Avg. volume:
645.5K
1-year change:
78.93%
Market cap:
$453.2M
Revenue:
$27.5M
EPS:
$-2.11

How Much Does Zevra Therapeutics Make?

Data Unavailable

Is Zevra Therapeutics Growing As A Company?

Data Unavailable

Zevra Therapeutics Stock Price Performance

What Is Zevra Therapeutics 52-Week High & Low?

Zevra Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Zevra Therapeutics?

Data Unavailable

Is Zevra Therapeutics Cash Flow Positive?

Data Unavailable

Zevra Therapeutics Return On Invested Capital

Data Unavailable

Zevra Therapeutics Earnings Date & Stock Price

Zevra Therapeutics Competitors

  • Who Are Zevra Therapeutics's Competitors?
    Below is a list of companies who compete with Zevra Therapeutics or are related in some way:
    • Ionis Pharmaceuticals Inc (IONS)
    • Johnson & Johnson (JNJ)
    • Vanda Pharmaceuticals Inc (VNDA)
    • Xeris Biopharma Holdings Inc (XERS)
    • Zoetis Inc (ZTS)

Zevra Therapeutics Dividend Yield

Data Unavailable

Zevra Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -68.29%
Revenue: 27.63% -24.01%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable